|
Volumn 48, Issue 1, 2001, Pages 137-144
|
Estrogen - A potential treatment for schizophrenia
|
Author keywords
Dopamine; Estrogen; Prolactin; Schizophrenia; Serotonin; Women
|
Indexed keywords
ESTRADIOL;
LUTEINIZING HORMONE;
NEUROLEPTIC AGENT;
PLACEBO;
PROLACTIN;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOPAMINERGIC SYSTEM;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENTIATION;
FEMALE;
HUMAN;
LUTEINIZING HORMONE BLOOD LEVEL;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
SCHIZOPHRENIA;
SEROTONINERGIC SYSTEM;
TREATMENT OUTCOME;
ADMINISTRATION, CUTANEOUS;
ADULT;
ANALYSIS OF VARIANCE;
ANTIPSYCHOTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
ESTRADIOL;
FEMALE;
HUMANS;
RISPERIDONE;
SCHIZOPHRENIA;
|
EID: 0035280803
PISSN: 09209964
EISSN: None
Source Type: Journal
DOI: 10.1016/S0920-9964(00)00088-8 Document Type: Article |
Times cited : (208)
|
References (28)
|